bioecon Member area
Technology · Services, governance & capital / Digital & IT

AI strain-design & engineering platforms

AI-native software platforms that design microbial strains, proteins and antibodies computationally — generative models, protein language models and closed-loop automated labs — distinct from the traditional wet-lab strain-engineering CRO service model.

Bioinformatics & Computation Risk: medium Digital & robotics US · EU Science: why it works → verified 2026-08-17 · 5 Sources (0 independent)

1 · What it gives

AI strain-design and engineering platforms are a B2B services category providing AI-native software that designs microbial strains, proteins and antibodies computationally, distinct from the traditional wet-lab strain-engineering contract-research-organization model. Ginkgo Bioworks launched Ginkgo Cloud Lab in 2026, a browser-based interface letting researchers run biological protocols on its autonomous lab infrastructure directly, transitioning benchwork to cloud-accessible automation. Absci runs Origin-1, a generative AI platform for de novo antibody design against novel epitopes, and collaborated with Twist Bioscience to combine its generative-AI drug-creation platform with DNA synthesis to accelerate novel therapeutic antibody design. Cradle runs an AI protein-design platform, with its CRADLE-1 model performing automated lead optimization of proteins as a next step beyond de novo generation. LabGenius operates a closed-loop discovery platform built around its EVA platform, unlocking high-performing molecules with non-intuitive designs across binder, linker and half-life-extension-domain building blocks. EvolutionaryScale develops the ESM (Evolutionary Scale Modeling) family of protein language models, open-sourced and widely adopted, with thousands of GitHub stars reflecting broad developer and research uptake.

The key directions of AI strain-design and engineering platforms are:

  1. Generative protein design models: AI models that generate novel protein and antibody structures de novo against specified targets or epitopes, rather than screening natural variants.
  2. Autonomous lab infrastructure: cloud-accessible robotic lab infrastructure letting researchers run biological protocols remotely through a software interface.
  3. Closed-loop design-build-test-learn platforms: integrated platforms where AI-generated designs are automatically built, tested and the results fed back to improve the next design cycle.
  4. Protein language models: large-scale models trained on protein sequence/structure data, providing a foundational layer for downstream generative design and lead-optimization tools.

Sectoral value chain#

[Target/epitope specification] ──> [AI-generated candidate design] ──> [Automated build/synthesis]
                                                                        │
                                                              (Closed-loop testing)
                                                                        │
              [Lead candidate selection] <──── [Data feedback to model] <─── [Functional/binding assay]

Value chain levels#

LevelDescriptionKey inputs/outputs
Target/epitope specificationDefining the target protein, epitope or functional specification the AI design process must satisfy.In: Research/therapeutic objective.
Out: Target specification.
AI-generated candidate designGenerative or protein-language models produce novel candidate protein, antibody or strain designs against the specification.In: Target specification.
Out: Candidate design set.
Automated build/synthesisCandidate designs are synthesized or constructed, often via automated or robotic lab infrastructure.In: Candidate design set.
Out: Physical candidate constructs.
Functional/binding assayPhysical candidates are tested for the target function or binding property in automated assays.In: Physical candidate constructs.
Out: Assay results.
Data feedback to modelAssay results are fed back into the AI model to improve subsequent design rounds.In: Assay results.
Out: Updated model/training data.
Lead candidate selectionThe best-performing candidates from the closed-loop cycle are selected as leads for further development.In: Updated model/training data, assay results.
Out: Selected lead candidates.

Cross-cutting technologies of the sector:

  • Generative protein design models: AI models generating novel protein and antibody structures de novo against a specified target or epitope.
  • Autonomous lab infrastructure: cloud-accessible robotic lab infrastructure letting researchers run biological protocols remotely through a software interface.
  • Closed-loop design-build-test-learn: integrated platforms where AI-generated designs are automatically built, tested and the results fed back to improve subsequent design cycles.

2 · What it replaces 3 · matched by industry

D3E–Agricultural spraying drones instead of knapsack and manned aerial spraying
Replaces: Manual knapsack spraying, tractor spraying in small or wet fields, and manned aircraft/helicopter spraying
EAC
D2E–Drone release of beneficial insects (Trichogramma, Cotesia, predatory mites) instead of insecticide sprays
Replaces: Insecticide sprays against caterpillar and mite pests, and manual walking release of natural enemies (the labour bottleneck of large-scale …
MACRO
D3E2Genomic selection in dairy cattle breeding instead of progeny testing
Replaces: Progeny testing — choosing AI bulls only after their daughters' milk records were available (5–6 years per bull and large testing costs)
BREED

3 · How to implement 6 steps

  1. 1
    Target/epitope specification
    The target protein, epitope or functional specification the AI design process must satisfy is defined.
  2. 2
    AI-generated candidate designData, software & automation
    Generative or protein-language models produce novel candidate protein, antibody or strain designs against the specification.
    Who can do this step matched automatically
    N.Thing South Korea
    industrial scale
    “Established in January 2014, N.THING is a Seoul-based Agri-Food tech company leading innovation in agricultural products, by extension, in the farm-to-table food value chain by …”
    “Founded in 2016 and based in Singapore and Japan, UMITRON builds user-friendly aquaculture data platforms that leverage the use of state of the art technologies such as IoT, AI and …”
    Stellapps India
    240,000 liters/day
    “It leverages advanced analytics and artificial intelligence through its full-stack IoT platform to enable dairy ecosystem partnerships with financial & insurance institutions, …”
    MIRAI Japan
    industrial scale
    “It also runs IoT/“SensorCorpus” software for monitoring/optimization, and its cultivation tech has been described as LED/water/airflow method optimization (e.g., “heavy lettuce”); …”
    Archisen Singapore
    industrial scale
    “We democratise urban farming and food access via IoT, automation and data analytics.”
  3. 3
    Automated build/synthesisSynthesis & conversionEquipment & engineering
    Candidate designs are synthesized or constructed, often via automated or robotic lab infrastructure.
    Who can do this step matched automatically
    N.Thing South Korea
    industrial scale
    “Services: turnkey delivery including design, construction, and operations consulting; in-house cultivation and supply to grocery, food service, catering, and manufacturing.”
    Cell AgriTech Malaysia
    5,000 L industrial scale
    “We design and fabricate our own stainless-steel bioreactors, automation systems, and harvesting modules, which lower CAPEX and OPEX by more than 80% compared to pharma-grade …”
    Daedong South Korea
    “Daedong is a South Korean agricultural machinery manufacturer founded in 1947 and headquartered in Daegu.”
    industrial scale
    “Core technology includes an in-house full-stack farming automation platform (SeaCombine, automated seeding/harvesting, data dashboards, weather/drone monitoring) and a …”
    Archisen Singapore
    industrial scale
    “It specializes in turnkey urban vertical-farming solutions using Controlled-Environment Agriculture (CEA).”
    163,050 tonnes
    “Uniquely equipped with the credentials for the R&D, design, and production of both high-efficiency dust filtration materials and SCR denitration catalysts, as well as for the …”
  4. 4
    Functional/binding assayTesting & analytics
    Physical candidates are tested for the target function or binding property in automated assays.
    Who can do this step matched automatically
    Turion Labs Singapore
    “Turion Labs is a Singapore-headquartered biotech innovation platform that provides shared laboratory infrastructure, contract research organization (CRO) services, and regulatory …”
    “LATU is a national and international reference in innovation, technology transfer and value solutions in analytical services, conformity assessment, metrology and technological …”
  5. 5
    Data feedback to model
    Assay results are fed back into the AI model to improve subsequent design rounds.
  6. 6
    Lead candidate selection
    The best-performing candidates from the closed-loop cycle are selected as leads for further development.

4 · Who delivers

Matched suppliers (matched automatically)

Ginkgo BioworksUnited StatesProduceractive
b.fab GmbHGermanyProduceractive
21st.BIODenmarkProduceractive
Tsingke BiotechnologyChinaProduceractive
ImperagenUnited KingdomEquipmentactive
KansenBio 绿色康成ChinaProduceractive
Molecular Trait EvolutionUnited StatesProduceractive
SyncoZymes (Shanghai)ChinaProduceractive
Isomorphic LabsUnited KingdomResearch / RTOactive

In the services and supply catalogue 2 · paid service

LIMS / MES & lab informatics · Process modelling & simulation

Leading companies and institutes (from the brief)

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
Ginkgo Bioworks🇺🇸 USAGinkgo Cloud LabBrowser-based autonomous lab accesscommercial
Absci🇺🇸 USAOrigin-1 generative antibody designDe novo design against novel epitopescommercial
Cradle🇳🇱 NetherlandsCRADLE-1 protein designAutomated lead optimizationcommercial
LabGenius🇬🇧 UKEVA closed-loop discovery platformNon-intuitive high-performing designscommercial
EvolutionaryScale🇺🇸 USAESM protein language modelsOpen-source, broad developer adoptioncommercial

5 · Rules & route to market

Route into Russia / EAEU: EAC · EAEU accredited bodies / Rosakkreditatsiya
declaration registered within 3 working days (testing extra); certification longer
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States

The United States hosts the leading AI-native strain, protein and antibody design platforms, spanning cloud lab infrastructure, generative drug design and open-source protein language models.

Ginkgo Bioworks’ Cloud Lab, Absci’s Origin-1 antibody design, EvolutionaryScale’s ESM models#

  • Ginkgo Bioworks: launched Ginkgo Cloud Lab in 2026, a browser-based interface letting researchers run biological protocols on its autonomous lab infrastructure directly, transitioning benchwork to cloud-accessible automation.
  • Absci: runs Origin-1, a generative AI platform for de novo antibody design against novel epitopes, and collaborated with Twist Bioscience to combine generative-AI drug creation with DNA synthesis.
  • EvolutionaryScale: develops the ESM (Evolutionary Scale Modeling) family of protein language models, open-sourced and widely adopted across the research community.

European Union

Europe hosts specialist AI protein-engineering platforms in the Netherlands and UK, applying generative and closed-loop design methods to lead optimization and novel molecule design.

Cradle’s automated lead optimization, LabGenius’ closed-loop discovery platform#

  • Cradle: headquartered in the Netherlands, runs an AI protein-design platform, with its CRADLE-1 model performing automated lead optimization of proteins as a next step beyond de novo generation.
  • LabGenius: headquartered in the UK, operates a closed-loop discovery platform built around its EVA platform, unlocking high-performing molecules with non-intuitive designs.

China

China is covered qualitatively rather than through a live-screened Chinese vendor: candidate Chinese AI strain-design platforms searched during this screen returned no confirming 2026 source specific to this service category.

No China-headquartered vendor confirmed in this screen#

  • Search outcome: two candidate Chinese firms were searched during this screen and neither returned a confirming live 2026 source for this specific service category.
  • Market presence: China has substantial synthetic-biology R&D investment, but no China-headquartered AI-native strain/protein-design platform vendor was independently confirmed in this screen.

6 · Money: tenders & grants

7 · Tech stack & innovations

The AI strain-design and engineering platform technology stack combines generative modeling, protein language models and closed-loop automation to compress design cycles:

  1. Generative de novo protein/antibody design:
    • Absci’s Origin-1 generates novel antibody candidates de novo against specified novel epitopes, moving beyond screening natural antibody libraries.
  2. Automated lead optimization beyond de novo generation:
    • Cradle’s CRADLE-1 model performs automated lead optimization as a distinct next step after de novo protein generation, refining candidates toward manufacturability and performance.
  3. Cloud-accessible autonomous lab infrastructure:
    • Ginkgo Bioworks’ Cloud Lab lets researchers transition benchwork directly to autonomous lab infrastructure through a browser interface, removing physical-lab-access as a bottleneck.

Sources 5 · 0 independent · 5 producer sites

Producers' own sites 5

  1. Ginkgo bioworks producer checked 2026-06-26 · link not kept
  2. Absci producer checked 2026-08-11 · link not kept
  3. Cradle producer checked 2026-07-23 · link not kept
  4. Labgenius producer checked 2026-07-29 · link not kept
  5. Evolutionaryscale producer checked 2024-06-25 · link not kept